Rational peptide selection to detect human immunodeficiency virus type 1-specific T-cell responses under resource-limited conditions.
Willberg CB., Pillai SK., Sharp ER., Rosenberg MG., Agudelo JD., Barbour JD., Nixon DF.
Understanding human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses is important for the development of vaccines and therapies. We describe a novel method for the rational selection of peptides that target stable regions of the HIV-1 genome, rich in epitopes specifically recognized by the study population. This method will be of particular use under resource/sample-limited conditions.